Abbott Laboratories (LON:0Q15)

Market Cap	171.36B
Revenue (ttm)	32.77B
Net Income (ttm)	10.41B
Shares Out	n/a
EPS (ttm)	5.96
PE Ratio	16.46
Forward PE	n/a
Dividend	1.77 (1.36%)
Ex-Dividend Date	Apr 15, 2025

Volume	9,201
Average Volume	5,666
Open	126.90
Previous Close	125.70
Day's Range	125.25 - 134.09
52-Week Range	104.15 - 121.60
Beta	0.66
RSI	57.46
Earnings Date	Apr 16, 2025

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1888
• Employees: 114,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Q15

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD